1. Home
  2. BGLC vs KXIN Comparison

BGLC vs KXIN Comparison

Compare BGLC & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • KXIN
  • Stock Information
  • Founded
  • BGLC N/A
  • KXIN 2015
  • Country
  • BGLC Malaysia
  • KXIN China
  • Employees
  • BGLC 30
  • KXIN N/A
  • Industry
  • BGLC Medical Specialities
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • BGLC Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • BGLC 9.2M
  • KXIN 7.5M
  • IPO Year
  • BGLC N/A
  • KXIN N/A
  • Fundamental
  • Price
  • BGLC $0.51
  • KXIN $0.12
  • Analyst Decision
  • BGLC
  • KXIN
  • Analyst Count
  • BGLC 0
  • KXIN 0
  • Target Price
  • BGLC N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • KXIN 1.8M
  • Earning Date
  • BGLC N/A
  • KXIN 11-26-2019
  • Dividend Yield
  • BGLC N/A
  • KXIN N/A
  • EPS Growth
  • BGLC N/A
  • KXIN N/A
  • EPS
  • BGLC N/A
  • KXIN N/A
  • Revenue
  • BGLC N/A
  • KXIN $31,535,000.00
  • Revenue This Year
  • BGLC N/A
  • KXIN N/A
  • Revenue Next Year
  • BGLC N/A
  • KXIN N/A
  • P/E Ratio
  • BGLC N/A
  • KXIN N/A
  • Revenue Growth
  • BGLC N/A
  • KXIN N/A
  • 52 Week Low
  • BGLC N/A
  • KXIN $0.11
  • 52 Week High
  • BGLC N/A
  • KXIN $5.52
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 54.22
  • KXIN 40.61
  • Support Level
  • BGLC $0.46
  • KXIN $0.12
  • Resistance Level
  • BGLC $0.55
  • KXIN $0.16
  • Average True Range (ATR)
  • BGLC 0.04
  • KXIN 0.01
  • MACD
  • BGLC 0.01
  • KXIN -0.00
  • Stochastic Oscillator
  • BGLC 44.29
  • KXIN 10.23

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: